Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RALAM Roll-Over: Simplification to QD Lamivudine + Raltegravir in HIV-1
NCT03311945Phase 3Completed
- Start
- May 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1). Started May 2018; status: completed.
02
Drugs
raltegravirlamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03311945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311945.